Ella graduated from her degree in Molecular Cell Biology and Organic Chemistry at UCL in 2019 to pursue a commercial and science communication-based role at Hanson Wade. She now manages a growing portfolio and team within the cell therapy business. Ella is passionate about developing events for this community which provide actionable insights to end-to-end cell therapy product development and commercialization experts, and scientific summits to explore the breaking wave of next-generation innate immune therapies.